Literature DB >> 20658642

Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease.

Gabriele Simonini, Ilaria Pagnini, Letizia Innocenti, Giovanni Battista Calabri, Maurizio De Martino, Rolando Cimaz.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20658642     DOI： 10.1002/pbc.22630

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  8 in total

Review 1.  Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.

Authors:  Mayan Gilboa; Gil Bornstein; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2019-07-31       Impact factor: 2.631

2.  Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges.

Authors:  Susumu Inoue; Chetna Mangat; Yaseen Rafe'e; Mahesh Sharman
Journal:  BMJ Case Rep       Date:  2015-01-29

Review 3.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

Review 4.  Macrophage Activation Syndrome.

Authors:  Ethan S Sen; Sarah L N Clarke; Athimalaipet V Ramanan
Journal:  Indian J Pediatr       Date:  2015-09-24       Impact factor: 1.967

Review 5.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

6.  Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.

Authors:  Karin Palmblad; Hanna Schierbeck; Erik Sundberg; Anna-Carin Horne; Helena Erlandsson Harris; Jan-Inge Henter; Ulf Andersson
Journal:  Mol Med       Date:  2021-05-11       Impact factor: 6.354

7.  Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.

Authors:  Raheleh Assari; Vahid Ziaee; Arash Mirmohammadsadeghi; Mohammad-Hassan Moradinejad
Journal:  Dis Markers       Date:  2015-04-30       Impact factor: 3.434

8.  High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.

Authors:  Karin Palmblad; Hanna Schierbeck; Erik Sundberg; Anna-Carin Horne; Helena Erlandsson Harris; Jan-Inge Henter; Daniel J Antoine; Ulf Andersson
Journal:  Mol Med       Date:  2015-01-27       Impact factor: 6.354
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.